Developmental Milestones. Borrower shall ensure that:
Developmental Milestones. Issuer shall ensure that:
Developmental Milestones. Novartis will notify Xxxxx of the first achievement of any of the Milestone Events set forth below within [***] after their achievement. In addition to (and not in lieu of) royalty payments due under this Agreement, Novartis shall pay to Xxxxx the following one-time, non-refundable, non-recoupable, non- creditable milestone payments no later than [***] after receipt of an invoice for the same, which will be issued following receipt of Novartis’ notice, via wire transfer in immediately available funds to the account specified in writing by Xxxxx: Milestone Event Milestone Payment [***] $ [*** ] [***] $ [*** ] [***] $ [*** ] Certain information marked as [***] has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
Developmental Milestones. Developmental Milestones by COMPANY for a LICENSED PRODUCT in accord with Paragraph 5.3 are as follows: Complete IND enabling study 2020 Initiate animal toxicology study last half 2020 File IND first half 2021 Complete PHASE I CLINICAL TRIAL first half of 2022 Commence PHASE II CLINICAL TRIAL 2024 Commence PHASE III CLINICAL TRIAL 2026 Regulatory approval, US or foreign equivalent 2026
Developmental Milestones. Subject to Section 4.2(c) below, within ninety (90) days of the first achievement of each of the milestone events set forth in the table below by Provention or any Related Party, Provention shall provide Vactech with written notice of such achievement and shall pay to Vactech the corresponding one-time milestone payment set forth below (each a “Developmental Milestone”):
Developmental Milestones. With respect to each Royalty Bearing Product, Licensee shall make the following non-creditable, non-refundable developmental milestone payments to DFCI within [***] days of the occurrence of the following events, whether Licensee, an Affiliate, Sublicensee, a permitted assignee, or a successor achieves the events. For the avoidance of doubt, all development milestone payments are payable [***]. Development Milestones for each Royalty Bearing Product Development Milestone Event Development Milestone Payment [***] $[***] [***] $[***] [***] $[***] [***] $[***] [***] $[***] [***] $[***]
Developmental Milestones. Company shall pay to JHU Developmental Milestones as set forth in Exhibit A. The Developmental Milestone payments shall be due, without the need for invoice from JHU, within Ninety (90) days of Company meeting the requirement of each milestone.
Developmental Milestones. The Developmental Milestones under Paragraph 3.4 are: Within thirty (30) days of the issuance of the first U.S. Patent from the PATENT RIGHTS Company will pay to JHU Twenty-five-thousand ($25,000) U.S. Dollars. Within thirty (30) days of the FIRST COMMERCIAL SALE of an Albumin-Bound Protein/Peptide Complex-based research product, company will pay to JHU Twenty-five Thousand ($25,000) U.S. Dollars. Within thirty (30) days of the submission of the first Albumin-Bound Protein/Peptide Complex-based test for regulatory approval in any country, company will pay to JHU One-hundred-thousand ($100,000) U.S. Dollars. Within thirty (30) days of FIRST COMMERCIAL SALE of an Albumin-Bound Protein/Peptide Complex-based approved diagnostic product, company will pay to JHU One-hundred-seventy-five Thousand ($175,000) U.S. Dollars.
Developmental Milestones. Within thirty (30) days after the first achievement of each of the milestone events set forth in the table below by Virpax or any Related Party in relation to a Product, Virpax shall provide MedPharm with written notice of such achievement and shall pay to MedPharm the corresponding one-time milestone payment set forth below (each a “Developmental Milestone”):
Developmental Milestones. As partial satisfaction of the requirements or the developmental program above and subject to the subsequent paragraph, Assignee shall achieve the following developmental milestones by the dates set forth below:
